In this edition of Null and Noteworthy, the Interagency Autism Coordinating Committee grapples with “groundbreaking” research and two reviews of interventions come to conflicting conclusions.

Shafali Jeste has spent the bulk of her scientific career searching for biological markers of autism. Her goal: to improve lives through early diagnosis and speedy testing of therapies.

A potential new gene therapy delivered via a single injection mimics ratios of proteins normally found in cells.

Andrew Whitehouse talks about his conservation efforts in the Australian Outback, what it’s like to be an identical twin and why he leaves work promptly at 5 p.m.

People with autism have more mutations than others do in both mitochondrial DNA and nuclear DNA that affects mitochondrial function.

Many autistic children rate the therapy as less effective at treating their anxiety than their parents and clinicians do.

A MECP2 gene therapy for Rett syndrome eases repetitive behaviors, anxiety and hyperactivity in a mouse model of Pitt-Hopkins syndrome.

These short reports from Spectrum journalists highlight some of the autism-related findings that caught our attention at the meeting this past week.

Cannabis-derived drugs are approved to treat only a small number of autism-related conditions, but many autistic people and their families experiment with medical marijuana to ease autism traits. In this special report, Spectrum rounds up what the science says about cannabis and autism.

Dysfunctional circuits and a rogue sodium channel in the brainstem may explain the disordered breathing pattern seen in children with Pitt-Hopkins syndrome, a form of autism.